Ro launches GLP-1 supply tracker to help patients overcome shortages
Zoom in iconArrows pointing outwards Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular…
Novo Nordisk A/S
Eli Lilly's big investment in GLP-1, plus CRM, BBY, FL and COST earnings next week
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Eli Lilly and Novo Nordisk develop weekly insulin
A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | fake images Do you think a friend…
AstraZeneca will increase its revenues and launch new drugs by 2030
Astrazeneca's logo appears at the 2021 World Artificial Intelligence Conference in Shanghai, China on July 7, 2021. Costofoto | Future…
Hims & Hers Weight Loss Adds GLP-1 Compound Injections
His and hers products are shown. His and hers Digital pharmacy startup Health for him and her is introducing access…
Roche's weight-loss drug shows promising results in early trial
A logo at the headquarters of Roche Holding AG in Basel, Switzerland, Thursday, February 1, 2024. Bloomberg | fake images…
1 in 8 adults have taken GLP-1 like Ozempic: survey
Rebekah Carl poses with her Wegovy recipe in New Columbia, Pennsylvania, USA, November 13, 2023. Hannah Beier | Reuters Do…
Wegovy Patients Maintain Weight Loss for 4 Years: Novo Nordisk Study
Boxes of Wegovy manufactured by Novo Nordisk in a pharmacy in London, Britain, on March 8, 2024. Hollie Adams |…
3.6 million Medicare patients could get heart health coverage
More than 3 million people with Medicare could be eligible for Wegovy coverage now that the hit weight-loss drug is…
Eli Lilly and Novo Nordisk increase the offer of weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…